You have read all your free articles, to continue reading subscribe to read the rest of this content.
Dignitana announces that the DigniCap scalp cooling system, which was cleared in December 2015 by the FDA to reduce the likelihood of chemotherapy-induced hair loss in women with breast cancer, will soon be available in nine additional medical centers across the United States including the four locaAlready a subscriber Login…
Dignitana is partnering with the organization known as CHILL, Cancer-related Hair Loss, International Leadership and Linkage, which was launched this past weekend at the 2017 Annual Meeting of the Multinational Association of Supportive Care in Cancer (MASCC), held in Washington, D.C. Led by six Already a subscriber Login You have…
Biotage has entered into an agreement to acquire Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences. The enterprise value for Astrea is approximately 190 million USD, subject to any closing adjustments and potential milestone-based payments, states the cAlready a subscriber Login You have read all your free articles,…
The US Patent and Trademark Office (USPTO) published an Issue of Notification of granting the company's patent application for a method with the medical device, which is one of the components in the product candidate SC0806. The notification states that the US patent will be granted and enters inAlready a…
